Erratum: Cost-effectiveness of everolimus for the treatment of advanced neuroendocrine tumours of gastrointestinal or lung origin in Canada
Curr Oncol
.
2018 Aug;25(4):e354-e355.
doi: 10.3747/co.25.4233.
Epub 2018 Aug 14.
Authors
A Chua
,
A Perrin
,
J F Ricci
,
M P Neary
,
M Thabane
PMID:
30111982
PMCID:
PMC6092055
DOI:
10.3747/co.25.4233
Abstract
[This corrects the article on p. 32 in vol. 25, PMID: 29507481.].
Publication types
Published Erratum